Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Human Gene Therapy
|
March 27, 1999
Thymidine kinase-deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor-directed gene therapy
M Puhlmann, M Gnant, C K Brown, et al.
Der Unfallchirurg
|
October 1, 1994
[Bridging long tibial shaft defects by partially demineralized bone matrix]
K K Hallfeldt, H Stützle, M Puhlmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2000
A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver
H R Alexander, S K Libutti, D L Bartlett, et al.
Cancer Gene Therapy
|
March 4, 2000
Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant
M Puhlmann, C K Brown, M Gnant, et al.
Gene Therapy
|
August 3, 2000
Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression
J A McCart, M Puhlmann, J Lee, et al.
Journal of the National Cancer Institute
|
October 21, 1999
Tumor-specific gene delivery using recombinant vaccinia virus in a rabbit model of liver metastases
M F Gnant, L A Noll, K R Irvine, et al.
Cancer Research
|
September 24, 1999
Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus
M F Gnant, A C Berger, J Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 18, 2021
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma
S Horwitz, O A O'Connor, B Pro, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Human Gene Therapy
|
March 27, 1999
Thymidine kinase-deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor-directed gene therapy
M Puhlmann, M Gnant, C K Brown, et al.
Der Unfallchirurg
|
October 1, 1994
[Bridging long tibial shaft defects by partially demineralized bone matrix]
K K Hallfeldt, H Stützle, M Puhlmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2000
A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver
H R Alexander, S K Libutti, D L Bartlett, et al.
Cancer Gene Therapy
|
March 4, 2000
Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant
M Puhlmann, C K Brown, M Gnant, et al.
Gene Therapy
|
August 3, 2000
Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression
J A McCart, M Puhlmann, J Lee, et al.
Journal of the National Cancer Institute
|
October 21, 1999
Tumor-specific gene delivery using recombinant vaccinia virus in a rabbit model of liver metastases
M F Gnant, L A Noll, K R Irvine, et al.
Cancer Research
|
September 24, 1999
Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus
M F Gnant, A C Berger, J Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 18, 2021
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma
S Horwitz, O A O'Connor, B Pro, et al.
Page
of 2